A study on the safety and immune responses to the GVGH altSonflex1-2-3 vaccine against shigellosis in adults, children, and infants

Trial Identifier:	212149
Sponsor:	GlaxoSmithKline
Start Date:	October 2021
Primary Completion Date:	June 2025
Study Completion Date:	June 2025

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
BELGIUM	Gent, BELGIUM, 9000
KENYA	Kericho, KENYA, 20200

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.